Access to antimalarial therapy: Accurate diagnosis is essential to achieving long term goals

BMJ (Online)

Volumn 339, Issue 7716, 2009, Pages 324-326

  Hopkins, Heidi ^a   Asiimwe, Caroline ^a   Bell, David ^b  

^a Foundation for Innovative Diagnostics (FInD)   (Uganda)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

AFRICA; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; GOAL ATTAINMENT; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HUMAN; MALARIA; MICROSCOPY; PREVALENCE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; GOALS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA;

EID: 69449107354     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy. Acta Trop 2005;95:305-315
2. WHO. World malaria report 2008. Geneva: WHO, 2008.
3. United Nations. The millennium development goals report. Washington, DC: UN, 2008.
4. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001;64(1-2 suppl):12-17 (Pubitemid 32552567)
5. Bate R, Coticelli P, Tren R, Attaran A. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS One 2008;3:e2132. (Pubitemid 352025174)
6. Roll Back Malaria Partnership AMFm Task Force. Affordable Medicines Facility for malaria (AMFm): technical design. 2007. www.rollbackmalaria.org/ partnership/tf/globalsubsidy/AMFmTechProposal.pdf.
7. Kachur PS, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, et al. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health 2006;11:441-451
8. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis 2008;197:510-518 (Pubitemid 351321527)
9. Gwer S, Newton CR, Berkley JA. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg 2007;77(suppl 6):6-13.
10. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004;329:1212. (Pubitemid 39551443)
11. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007;4:e309.
12. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini U, Ogbamariam A, et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J 2006;5:33.
13. Roll Back Malaria/WHO. Global strategic plan 2005-2015. www.rollbackmalaria.org/forumV/docs/gsp-en.pdf.
14. Kallander K, Hildenwall H, Waiswa P, Galiwango E, Peterson S, Pariyo G. Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study. Bull World Health Organ 2008;86:332-338 (Pubitemid 351694312)
15. Berkley JA, Mwangi I, Mellington F, Mwarumba S, Marsh K. Cerebral malaria versus bacterial meningitis in children with impaired consciousness. Q J Med 1999;92:151-157 (Pubitemid 29116951)
16. Djimde A, Plowe CV, Diop S, Dicko A, Wellems TE, Doumbo O. Use of antimalarial drugs in Mali: policy versus reality. Am J Trop Med Hyg 1998;59:376-379 (Pubitemid 28429075)
17. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 2004;71(suppl 2):179-186 (Pubitemid 39121321)
18. WHO. Global malaria control and elimination: Report of a meeting on containment of artemisinin tolerance. Geneva: WHO, 2008.
19. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004;364:1896-1898 (Pubitemid 39536094)
20. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJM, et al. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 2008;86:101-110 (Pubitemid 351213713)
21. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJM, et al. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ 2008;336:202-205 (Pubitemid 351212677)
22. Zikusooka CM, McIntyre D, Barnes KI. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 2008;7:176.
23. WHO. Guidelines for the treatment of malaria. Geneva: WHO, 2006.
24. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, et al. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 2003;3:99-102. (Pubitemid 36164206)
25. WHO, Foundation for Innovative New Diagnostics. Methods manual for laboratory quality control testing of malaria rapid diagnostic tests. 2008. www.wpro.who.int/NR/rdonlyres/B5446BF5-BCFA-427D-B9FE-CEA57D36B92B/0/ DTLaboratoryQCtestingMethManuV5aWEBVERSIONAug2008.pdf.
26. WHO. Malaria rapid diagnostic tests evaluation programme. www.wpro.who.int/sites/rdt/who-rdt-evaluation/.
27. WHO. Malaria rapid diagnostic tests evaluation programme. Lot testing. www.wpro.who.int/sites/rdt/who-rdt-evaluation/lot-testing.htm.
28. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 2007;297:2227-2231 (Pubitemid 47010880)
29. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 2007;334:403. (Pubitemid 46374647)